-transparent.png){kind=logo}
The purpose of this study was to elucidate the pharmacokinetics of terazosin enantiomers in healthy Chinese male subjects. After a single oral dose of 2-mg terazosin, the plasma concentrations of terazosin enantiomers were measured over the course of 48 h in 12 healthy subjects. The plasma concentrations of (+)-(R)-terazosin at all time points were higher than those of (-)-(S)-terazosin. The area under the plasma concentration-time curve (AUC(0-∞) ) and maximum plasma concentration of (+)-(R)-terazosin were significantly greater than those of the (-)-(S)-terazosin (P < 0.01, respectively). The R/S ratio of AUC(0-∞) of terazosin was 1.68. For the first time, it was proven that the pharmacokinetics of terazosin was stereoselective in healthy Chinese male subjects.
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
March 2007,
Chirality,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
May 2007,
British journal of clinical pharmacology,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
April 1999,
Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
September 2008,
International journal of clinical pharmacology and therapeutics,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
February 2000,
Anesthesiology,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
July 1998,
International journal of clinical pharmacology and therapeutics,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
April 1999,
Clinical pharmacology and therapeutics,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
August 1999,
British journal of clinical pharmacology,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
April 2013,
European journal of clinical pharmacology,
Man Liu, and
Dan Zhang, and
Man Yang, and
Ting Zhao, and
Xiaolin Wang, and
Yanan Zhang, and
Jing Han, and
Huichen Liu
January 1988,
Journal of pharmaceutical sciences,
